Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

COVID-19 Testing: What You Should Know



COVID-19 Testing: What You Should Know

Wednesday, October 14, 2020, 11:30 AM - 12:45 PM EDT


Presented By

The New York Academy of Sciences


The emergence of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), swiftly evolved into a global pandemic in early 2020.  With more than 30 million people infected worldwide and almost one million deaths to date, the novel coronavirus continues to wreak havoc on societies across the globe.

Large-scale diagnostic testing is a crucial epidemiological tool for containing the spread of infectious diseases like COVID-19 and is widely viewed as key to safely reopening schools and economies.  It is critical to understand who has the disease so that proper medical care, contact tracing, and isolation can be implemented, especially given that 40% of SARS-CoV-2 transmission events occur before the onset of symptoms.

This panel discussion will open by delving into the science behind COVID-19 testing types (e.g, molecular, antigen, serological), as well as the pros and cons of each.  Real world applications of these tests will be discussed in terms of how they function in society.  What are the current successes and failures of these tests and what is really needed to more safely open schools, return to offices, and engage in other activities?  How can testing be better democratized so that all socio-economic sectors have equal access?  Innovation is abundant for COVID-19 testing — understanding how new COVID-19 diagnostics are evaluated by the FDA for regulatory approval or Emergency Use Authorization will also be explored alongside novel ideas for next generation tests.


Nonmember Student, Undergrad, Grad, Fellow
Member Student, Post-Doc, Fellow


Apoorva Mandavilli, MS
Apoorva Mandavilli, MS

New York Times


Michael Mina
Michael Mina, MD, PhD

Harvard T.H. Chan School of Public Health

Gail Radcliffe
Gail Radcliffe, PhD

Radcliffe Consulting, Inc.

Beatus Ofenloch-Haehnle
Beatus Ofenloch-Haehnle